Literature DB >> 24452537

The phenotype and activation status of regulatory T cells during Friend retrovirus infection.

Jara J Joedicke1, Kirsten K Dietze, Gennadiy Zelinskyy, Ulf Dittmer.   

Abstract

The suppressive capacity of regulatory T cells (Tregs) has been extensively studied and is well established for many diseases. The expansion, accumulation, and activation of Tregs in viral infections are of major interest in order to find ways to alter Treg functions for therapeutic benefit. Tregs are able to dampen effector T cell responses to viral infections and thereby contribute to the establishment of a chronic infection. In the Friend retrovirus (FV) mouse model, Tregs are known to expand in all infected organs. To better understand the characteristics of these Treg populations, their phenotype was analyzed in detail. During acute FV-infection, Tregs became activated in the spleen and bone marrow, as indicated by various T cell activation markers, such as CD43 and CD103. Interestingly, Tregs in the bone marrow, which contains the highest viral loads during acute infection, displayed greater levels of activation than Tregs from the spleen. Treg expansion was driven by proliferation but no FV-specific Tregs could be detected. Activated Tregs in FV-infection did not produce Granzyme B (GzmB) or tumor necrosis factor α (TNFα), which are thought to be a potential mechanism for their suppressive activity. Furthermore, Tregs expressed inhibitory markers, such as TIM3, PD-1 and PD-L1. Blocking TIM3 and PD-L1 with antibodies during chronic FV-infection increased the numbers of activated Tregs. These data may have important implications for the understanding of Treg functions during chronic viral infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452537      PMCID: PMC8206416          DOI: 10.1007/s12250-014-3396-z

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  58 in total

1.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.

Authors:  Naoshi Sugimoto; Takatoku Oida; Keiji Hirota; Kyoko Nakamura; Takashi Nomura; Takashi Uchiyama; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2006-06-13       Impact factor: 4.823

2.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

3.  A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease.

Authors:  Justin R Killebrew; Nikole Perdue; Alan Kwan; Angela M Thornton; Ethan M Shevach; Daniel J Campbell
Journal:  J Immunol       Date:  2011-06-20       Impact factor: 5.422

4.  Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage.

Authors:  Julie Cabarrocas; Cécile Cassan; Fay Magnusson; Eliane Piaggio; Lennart Mars; Jens Derbinski; Bruno Kyewski; David-Alexandre Gross; Benoit L Salomon; Khashayarsha Khazaie; Abdelhadi Saoudi; Roland S Liblau
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-18       Impact factor: 11.205

5.  Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens.

Authors:  George A Punkosdy; Melissa Blain; Deborah D Glass; Mary M Lozano; Leigh O'Mara; Jaquelin P Dudley; Rafi Ahmed; Ethan M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

6.  In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells.

Authors:  Shelly J Robertson; Ronald J Messer; Aaron B Carmody; Kim J Hasenkrug
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

7.  Viral antigen induces differentiation of Foxp3+ natural regulatory T cells in influenza virus-infected mice.

Authors:  Felipe Bedoya; Guang-Shing Cheng; Abigail Leibow; Nardine Zakhary; Katherine Weissler; Victoria Garcia; Malinda Aitken; Elizabeth Kropf; David S Garlick; E John Wherry; Jan Erikson; Andrew J Caton
Journal:  J Immunol       Date:  2013-05-10       Impact factor: 5.422

8.  Helios expression is a marker of T cell activation and proliferation.

Authors:  Tatiana Akimova; Ulf H Beier; Liqing Wang; Matthew H Levine; Wayne W Hancock
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

9.  IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infection.

Authors:  Lara Myers; Jara J Joedicke; Aaron B Carmody; Ronald J Messer; George Kassiotis; Jaquelin P Dudley; Ulf Dittmer; Kim J Hasenkrug
Journal:  J Immunol       Date:  2013-05-03       Impact factor: 5.422

10.  Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection.

Authors:  George R Young; Mickaël J-Y Ploquin; Urszula Eksmond; Munisch Wadwa; Jonathan P Stoye; George Kassiotis
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

View more
  17 in total

1.  Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study.

Authors:  Cheng Chen; Wei Sun; Jun Chen; Jian-An Huang
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

2.  Interaction of viruses with host immune system and immunomodulation in chronic viral infections.

Authors:  Mengji Lu; Yumei Wen
Journal:  Virol Sin       Date:  2014-02       Impact factor: 4.327

3.  Expanded regulatory T cells in chronically friend retrovirus-infected mice suppress immunity to a murine cytomegalovirus superinfection.

Authors:  Janine Duppach; Sandra Francois; Jara J Joedicke; Ulf Dittmer; Anke R M Kraft
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

Review 4.  CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway.

Authors:  Pablo Penaloza-MacMaster
Journal:  Immunology       Date:  2017-04-25       Impact factor: 7.397

5.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis.

Authors:  Jing Lu; Zhihong Cen; Quan Tang; Jingwei Dong; Lin Qin; Weifeng Wu
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

6.  Neuropilin-1 is present on Foxp3+ T regulatory cell-derived small extracellular vesicles and mediates immunity against skin transplantation.

Authors:  Mauricio Campos-Mora; Javiera De Solminihac; Carolina Rojas; Cristina Padilla; Mónica Kurte; Rodrigo Pacheco; Thilo Kaehne; Úrsula Wyneken; Karina Pino-Lagos
Journal:  J Extracell Vesicles       Date:  2022-06

7.  The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis.

Authors:  Jing Lu; Zhihong Cen; Quan Tang; Jingwei Dong; Lin Qin; Weifeng Wu
Journal:  Clin Exp Immunol       Date:  2022-02-08       Impact factor: 5.732

8.  Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.

Authors:  Jara J Joedicke; Lara Myers; Aaron B Carmody; Ronald J Messer; Harald Wajant; Karl S Lang; Philipp A Lang; Tak W Mak; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

9.  Plasmodium vivax Infection Impairs Regulatory T-Cell Suppressive Function During Acute Malaria.

Authors:  Pedro A C Costa; Maria M Figueiredo; Suelen Q Diniz; Ana P M M Peixoto; Kevin J Maloy; Andréa Teixeira-Carvalho; Mauro S Tada; Dhelio B Pereira; Ricardo T Gazzinelli; Lis R V Antonelli
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 7.759

10.  Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection.

Authors:  Elisabeth Littwitz-Salomon; Ilseyar Akhmetzyanova; Cecilia Vallet; Sandra Francois; Ulf Dittmer; Kathrin Gibbert
Journal:  Retrovirology       Date:  2015-07-30       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.